The MAPK/ERK signaling pathway is another critical target for inhibitors. This pathway is involved in regulating cell differentiation, growth, and survival. Inhibitors targeting MAPK/ERK are used in cancer treatments to avoid unchecked cell proliferation and lump growth. JAK/STAT signaling inhibitors modulate immune actions and are utilized in deal